Across Europe continent, authorities are increasingly concerned by the rise of fentanyl and its analogues, a highly potent synthetic opioid. Initially detected in limited regions, its detection is now documented in a wider range of countries, such as Belgium and Ireland to Germany. While overall usage rates remain below those seen in North America,

Belgium has officially made available a new ketamine solution for mental health issues. This groundbreaking development represents a significant step forward in providing effective treatment options for patients suffering from PTSD, among other diseases. The ketamine solution, administered in a nasal spray form, has shown promising results in clini